Business Wire

Fresenius Kabi Introduces Bortezomib for Injection

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of Bortezomib for Injection. Fresenius Kabi Bortezomib for Injection is available as a single ...
FierceBiotech

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

CAMBRIDGE, Mass. and OSAKA, Japan, June 20 /PRNewswire/ -- Millennium Pharmaceuticals, The Takeda Oncology Company, and Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) today announced that ...
FierceBiotech

Takeda to Co-Promote VELCADE® (bortezomib) for Injection in Japan

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (“Takeda,” TSE:4502) and its wholly owned subsidiary Millennium: The Takeda Oncology Company (“Millennium”) ...
EurekAlert!

VELCADE® for injection receives EU marketing authorisation for second-line use in multiple myeloma

HIGH WYCOMBE, UK, 28th April 2005 – Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, today announced that the European Commission has approved the use of VELCADE® (bortezomib) for ...
Nasdaq

Dr. Reddy's Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Seeking Alpha

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, and Shilpa Medicare ...
Reuters

Millennium Pharm Velcade for injection based therapies Produced Complete Remission Rates as High as 54%

Co reported on the presentation of results from clinical trials of Velcade based therapies that showed high complete remission / complete response rates in previously treated multiple myeloma patients ...
News Medical

DBL Bortezomib Powder for Injection

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Bortezomib Powder for Injection contains the active ingredient ...
Healthline

Velcade and Cost: What You Need to Know

Velcade (bortezomib) is a prescription drug that’s used to treat blood cancers such as multiple myeloma and mantle cell lymphoma. Velcade’s cost may depend on factors such as your dosage, whether you ...
Business Wire

Dr. Reddy's Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
The Financial

Takeda to Co-promote VELCADE (bortezomib) for Injection in Japan

The FINANCIAL — Takeda Pharmaceutical Company Limited (“Takeda,” TSE:4502) and its wholly owned subsidiary Millennium: The Takeda Oncology Company (“Millennium”) on May 10 announced that Takeda has ...